Full text is available at the source.
Gastroenterology··
A Circadian Regulator Controls Immune Response to Reduce Severe Liver Inflammation in Mice
Updated
Abstract
Expression of NLRP3 in peritoneal macrophages varies with time of day and is regulated by NR1D1.
- The activity of the NLRP3 inflammasome complex exhibits a circadian rhythm influenced by NR1D1.
- Macrophages lacking NR1D1 showed altered expression of NLRP3 and reduced production of inflammatory cytokines IL1B and IL18.
- Mice with disrupted Nr1d1 experienced more severe inflammation and liver failure compared to control mice.
- Activation of NR1D1 using SR9009 decreased NLRP3 expression and cytokine secretion in macrophages.
- Mice treated with SR9009 had less severe liver failure and longer survival times than those given a saline control.
Simplified
BACKGROUND & AIMS: The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the activity of the NLRP3 inflammasome. We investigated whether the core clock component nuclear receptor subfamily 1 group D member 1 (NR1D1, also called Rev-erbα) regulates expression, activity of the NLRP3 inflammasome, and its signaling pathway.
METHODS: We collected naïve peritoneal macrophages and plasma, at multiple times of day, from Nr1d1mice and their Nr1d1littermates (controls) and analyzed expression NLRP3, interleukin 1β (IL1B, in plasma), and IL18 (in plasma). We also collected bone marrow-derived primary macrophages from these mice. Levels of NR1D1 were knocked down with small hairpin RNAs in human primary macrophages. Bone marrow-derived primary macrophages from mice and human primary macrophages were incubated with lipopolysaccharide (LPS) to induce expression of NLRP3, IL1B, and IL18; cells were incubated with LPS and adenosine triphosphate to activate the NLRP3 complex. We analyzed caspase 1 activity and cytokine secretion. NR1D1 was activated in primary mouse and human macrophages by incubation with SR9009; some of the cells were also incubated with an NLRP3 inhibitor or inhibitors of caspase 1. Nr1d1mice and control mice were given intraperitoneal injections of LPS to induce peritoneal inflammation; plasma samples were isolated and levels of cytokines were measured. Nr1d1mice, control mice, and control mice given injections of SR9009 were given LPS and D-galactosamine to induce fulminant hepatitis and MCC950 to specifically inhibit NLRP3; plasma was collected to measure cytokines and a marker of liver failure (alanine aminotransferase); liver tissues were collected and analyzed by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry. -/-+/+ -/--/-
RESULTS: In peritoneal macrophages, expression of NLRP3 and activation of its complex varied with time of day (circadian rhythm)-this regulation required NR1D1. Primary macrophages from Nr1d1mice and human macrophages with knockdown of NR1D1 had altered expression patterns of NLRP3, compared to macrophages that expressed NR1D1, and altered patterns of IL1B and 1L18 production. Mice with disruption of Nr1d1 developed more-severe acute peritoneal inflammation and fulminant hepatitis than control mice. Incubation of macrophage with the NR1D1 activator SR9009 reduced expression of NLRP3 and secretion of cytokines. Mice given SR9009 developed less-severe liver failure and had longer survival times than mice given saline (control). -/-
CONCLUSIONS: In studies of Nr1d1mice and human macrophages with pharmacologic activation of NR1D1, we found NR1D1 to regulate the timing of NLRP3 expression and production of inflammatory cytokines by macrophages. Activation of NR1D1 reduced the severity of peritoneal inflammation and fulminant hepatitis in mice. -/-
Related papers
Mar '14
Lactate lowers liver and pancreas damage from immune-triggered inflammation by blocking innate immune response through GPR81
cited by 474 papers
research support, n.i.h., extramural
Jul '21
REV-ERBα activator SR9009 reduces inflammatory IL-1β in immune cells by blocking inflammasome through BMAL1
cited by 44 papers
research support, non-u.s. gov't
Nov '18
RORγ controls the activation of the NLRP3 inflammasome
top 10% journal
cited by 31 papers
research support, n.i.h., extramural
Aug '20
The role of Rev-erbα in liver damage from blood flow loss and restoration in mice
top 30% journal
cited by 13 papers
research support, non-u.s. gov't
Mar '19
Using a Liver Failure Model to Study How Activated Nuclear Receptors Affect the NLRP3 Inflammasome Pathway in Living Organisms
top 50% journal
cited by 8 papers
research support, non-u.s. gov't
Feb '21
Withaferin A may reduce severe liver inflammation by acting on immune cells and inflammatory pathways
top 5% journal
cited by 29 papers
research support, n.i.h., intramural
Sep '21
Isoliquiritigenin may reduce sudden liver failure by activating protective pathways that lower oxidative stress and inflammation
cited by 47 papers
journal article
Sep '13
Activation of the NLRP3 immune sensor in sudden liver failure caused by D-galactosamine and bacterial toxin: the role of heme oxygenase-1
top 5% journal
cited by 132 papers
research support, non-u.s. gov't
Dec '16
Chenodeoxycholic acid triggers inflammation and may contribute to liver scarring in bile flow blockage
top 30% journal
cited by 134 papers
journal article
Mar '18
Specialized fat molecules reduce the preparation and activation of immune cell inflammation triggers
top 10% journal
cited by 76 papers
research support, non-u.s. gov't